"Virginia Hospital Center has provided exceptional medical services to the Washington, DC metropolitan area for 75 years and was once again named a Leapfrog Top Hospital in 2018, and previously named one of America’s 100 Top Hospitals and 50 Top Cardiovascular Hospitals by Truven Health Analytics. The Hospital is a proud member of the Mayo Clinic Care Network – a national network of independent healthcare organizations. Virginia Hospital Center is a 394-bed not-for-profit, teaching facility, and it is designated as a Magnet hospital by the American Nurses Credentialing Center."

During the past decade, Virginia Hospital Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Virginia Hospital Center" #1 sponsor was "Pfizer" with 3 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Accuray Incorporated" with 1 trials sponsored and "Alexion" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia Hospital Center" #1 collaborator was "Procter and Gamble" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Virginia Hospital Center" are "Osteoarthritis" (3 trials), "COVID-19" (2 trials), "Asthma" (1 trials), "Breast Cancer" (1 trials) and "Cancer of the Prostate" (1 trials). Many other conditions were trialed in "Virginia Hospital Center" in a lesser frequency.

Most popular intervention types in "Virginia Hospital Center" are "Device" (4 trials), "Drug" (4 trials), "Biological" (3 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Remdesivir" (2 trials), "Standard of Care" (2 trials), "tanezumab" (2 trials), "Alair System" (1 trials) and "CyberKnife Stereotactic Radiosurgery" (1 trials). Other intervention names were less common.

The vast majority of trials in "Virginia Hospital Center" are 9 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Virginia Hospital Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Virginia Hospital Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Virginia Hospital Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".